C
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 410.5 KBCORIXA CORPJul 14, 9:50 PM ET·0001209191-05-037230
- 412.3 KBCORIXA CORPJul 14, 8:18 PM ET·0001209191-05-037227
- 47.9 KBCORIXA CORPJul 14, 8:17 PM ET·0001209191-05-037226
- 416.7 KBCORIXA CORPJul 14, 8:16 PM ET·0001209191-05-037225
- 443.0 KBCORIXA CORPJul 14, 8:08 PM ET·0001209191-05-037223
- 452.0 KBCORIXA CORPJul 14, 8:03 PM ET·0001209191-05-037221
- 462.2 KBCORIXA CORPJul 14, 7:37 PM ET·0001209191-05-037216
- 459.1 KBCORIXA CORPJul 14, 7:19 PM ET·0001209191-05-037208
- 422.7 KBCORIXA CORPJul 14, 5:02 PM ET·0001181340-05-000001
- 442.4 KBCORIXA CORPJul 14, 4:04 PM ET·0001207833-05-000009
Insiders
10- BIGHAM MICHAELDirector
- CREDIT SUISSE AG/10% Owner
- FANNING DAVIDSr. Vice President, COO
- GILLIS STEVENDirector, CEO
- GRABSTEIN KENNETHExec. VP, Product Development
- GRIFFIN MICHELLE RENEESr. Vice President, CFO
- GSK plc10% Owner
- HUNT RONALDDirector
- JACOBS CINDYSr. VP, Clinical Development
- MCKEREGHAN KATHLEENSr. VP,General Counsel
Tickers
No tickers on record
Addresses
business
1900 9TH AVENUE SUITE 1100
SEATTLE, WA, 98101
mailing
1900 9TH AVENUE SUITE 1100
SEATTLE, WA, 98101